ArticleTheranostics2022

Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.

Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.